Jiang Hua Mei
Direktor/Vorstandsmitglied bei SHANGHAI UNIVERSAL BIOTECH CO.,LTD.
Profil
Jiang Hua Mei is currently working as a Partner & Investment Director at Shanghai Changjiang Guohong Investment Management Co. Ltd.
Additionally, Mr. Mei holds the position of Director-Investment Division at Shanghai Grandyangtze Capital Co. Ltd.
since 2016.
Furthermore, Mr. Mei is a Member-Supervisory Board at Shanghai Universal Biotech Co., Ltd.
starting from 2018.
In the past, Mr. Mei worked as a Director at PharmaBlock Sciences (Nanjing), Inc. from 2014 to 2018.
Mr. Mei also served as a Member-Supervisory Board at TransThera Sciences (Nanjing), Inc. Regarding education, Mr. Mei obtained an MBA from Shanghai Jiao Tong University in 2015.
Mr. Mei completed their undergraduate degree at Zhejiang University in 2000 and their graduate degree from the same university in 2003.
Aktive Positionen von Jiang Hua Mei
| Unternehmen | Position | Beginn |
|---|---|---|
| SHANGHAI UNIVERSAL BIOTECH CO.,LTD. | Direktor/Vorstandsmitglied | 01.11.2018 |
Shanghai Changjiang Guohong Investment Management Co. Ltd.
 Shanghai Changjiang Guohong Investment Management Co. Ltd. Investment ManagersFinance Shanghai Changjiang Guohong Investment Management Co. Ltd. is a private equity firm headquartered in Shanghai, China. The firm was established in 2007. | Direktor/Vorstandsmitglied | - |
| Shanghai Grandyangtze Capital Co. Ltd. | Corporate Officer/Principal | 01.06.2016 |
Ehemalige bekannte Positionen von Jiang Hua Mei
| Unternehmen | Position | Ende |
|---|---|---|
| SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Direktor/Vorstandsmitglied | 09.11.2022 |
| PHARMABLOCK SCIENCES (NANJING), INC. | Direktor/Vorstandsmitglied | 01.11.2018 |
TransThera Sciences (Nanjing), Inc.
 TransThera Sciences (Nanjing), Inc. BiotechnologyHealth Technology TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China. | Direktor/Vorstandsmitglied | - |
Ausbildung von Jiang Hua Mei
| Shanghai Jiao Tong University | Masters Business Admin |
| Zhejiang University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PHARMABLOCK SCIENCES (NANJING), INC. | Commercial Services |
| SHANGHAI UNIVERSAL BIOTECH CO.,LTD. | Distribution Services |
| SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
TransThera Sciences (Nanjing), Inc.
TransThera Sciences (Nanjing), Inc. BiotechnologyHealth Technology TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China. | Health Technology |
| Shanghai Grandyangtze Capital Co. Ltd. | |
Shanghai Changjiang Guohong Investment Management Co. Ltd.
Shanghai Changjiang Guohong Investment Management Co. Ltd. Investment ManagersFinance Shanghai Changjiang Guohong Investment Management Co. Ltd. is a private equity firm headquartered in Shanghai, China. The firm was established in 2007. | Finance |
